학술논문
Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?
Document Type
Review Article
Author
Source
In Neuropharmacology 1 August 2024 253
Subject
Language
ISSN
0028-3908